QuartataWeb 1.0

2 known interactions (targets) of input drug (DB02644): N-Omega-Propyl-L-Arginine

No.	Gene	UniProt ID	Protein Name	Pathway	PDB
1	NOS1	P29475	Nitric oxide synthase, brain	hsa00220; hsa00330; hsa01100; hsa04020; hsa04145; hsa04371; hsa04713; hsa04730; hsa04926; hsa04970; hsa05010; hsa05014	4D1N; 4UCH; 4UH5; 4UH6; 4V3U; 5ADF; 5ADG; 5ADI
2	NOS2	P35228	Nitric oxide synthase, inducible	hsa00220; hsa00330; hsa01100; hsa04020; hsa04066; hsa04146; hsa04371; hsa04926; hsa05132; hsa05133; hsa05140; hsa05142; hsa05145; hsa05146; hsa05152; hsa05200; hsa05222	1NSI; 2LL6; 2NSI; 3E7G; 3EJ8; 3HR4; 4CX7; 4NOS

20 predicted interactions (targets) of input drug (DB02644): N-Omega-Propyl-L-Arginine

No.	Gene	UniProt ID	Protein Name	Pathway	PDB	Confidence score
1	NOS3	P29474	Nitric oxide synthase, endothelial	hsa00220; hsa00330; hsa01100; hsa04020; hsa04022; hsa04066; hsa04071; hsa04151; hsa04370; hsa04371; hsa04611; hsa04915; hsa04921; hsa04926; hsa04931; hsa04933; hsa05418	1M9J; 1M9K; 1M9M; 1M9Q; 1M9R; 1NIW; 2LL7; 2MG5; 3EAH; 3NOS; 4D1O; 4D1P	56.1%
2	NR3C1	P04150	Glucocorticoid receptor	hsa04080	1M2Z; 1NHZ; 1P93; 3BQD; 3CLD; 3E7C; 3H52; 3K22; 3K23; 4CSJ; 4HN5; 4HN6; 4LSJ; 4MDD; 4P6W; 4P6X	18.7%
3	PDE4A	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	hsa00230; hsa04024; hsa04928; hsa05032	2QYK; 3I8V; 3TVX	17.8%
4	PDE4D	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	hsa00230; hsa04024; hsa04928; hsa05032	1E9K; 1MKD; 1OYN; 1PTW; 1Q9M; 1TB7; 1TBB; 1XOM; 1XON; 1XOQ; 1XOR; 1Y2B; 1Y2C; 1Y2D; 1Y2E; 1Y2K; 1ZKN; 2FM0; 2FM5; 2PW3; 2QYN; 3G4G; 3G4I; 3G4K; 3G4L; 3G58; 3IAD; 3IAK; 3K4S; 3SL3; 3SL4; 3SL5; 3SL6; 3SL8; 3V9B; 4OGB; 4W1O; 4WCU	16.7%
5	TLR9	Q9NR96	Toll-like receptor 9	hsa04620; hsa05142; hsa05143; hsa05144; hsa05152; hsa05162; hsa05168	NA	15.2%
6	CACNA1C	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	hsa04010; hsa04020; hsa04022; hsa04024; hsa04260; hsa04261; hsa04270; hsa04713; hsa04720; hsa04723; hsa04724; hsa04725; hsa04726; hsa04727; hsa04728; hsa04742; hsa04911; hsa04912; hsa04921; hsa04924; hsa04925; hsa04927; hsa04930; hsa04934; hsa05010; hsa05031; hsa05410; hsa05412; hsa05414	1T0J; 2BE6; 2F3Y; 2F3Z; 2LQC; 3G43; 3OXQ	14.3%
7	HIF1A	Q16665	Hypoxia-inducible factor 1-alpha	hsa04066; hsa04137; hsa04140; hsa04659; hsa04919; hsa05167; hsa05200; hsa05205; hsa05211; hsa05230; hsa05231	1D7G; 1H2K; 1H2L; 1H2M; 1L3E; 1L8C; 1LM8; 1LQB; 2ILM; 3HQR; 3HQU; 4AJY; 4H6J	14.2%
8	KCNMB1	Q16558	Calcium-activated potassium channel subunit beta-1	hsa04022; hsa04270; hsa04911	NA	13.9%
9	GPHN	Q9NQX3	Gephyrin	hsa00790; hsa01100; hsa04727	1JLJ	13.8%
10	NR1I2	O75469	Nuclear receptor subfamily 1 group I member 2	NA	1ILG; 1ILH; 1M13; 1NRL; 1SKX; 2O9I; 2QNV; 3CTB; 3HVL; 3R8D; 4J5W; 4J5X; 4NY9; 4S0S; 4S0T; 4X1F; 4X1G; 4XAO; 4XHD; 5A86	13.7%
11	HAGH	Q16775	Hydroxyacylglutathione hydrolase, mitochondrial	hsa00620	1QH3; 1QH5; 2F50	13.7%
12	ODC1	P11926	Ornithine decarboxylase	hsa00330; hsa00480; hsa01100	1D7K; 2ON3; 2OO0; 4ZGY	13.3%
13	SHBG	P04278	Sex hormone-binding globulin	NA	1D2S; 1F5F; 1KDK; 1KDM; 1LHN; 1LHO; 1LHU; 1LHV; 1LHW	12.9%
14	PADI2	Q9Y2J8	Protein-arginine deiminase type-2	NA	4N20; 4N22; 4N24; 4N25; 4N26; 4N28; 4N2A; 4N2B; 4N2C; 4N2D; 4N2E; 4N2F; 4N2G; 4N2H; 4N2I; 4N2K; 4N2L; 4N2M; 4N2N	12.7%
15	OTC	P00480	Ornithine carbamoyltransferase, mitochondrial	hsa00220; hsa01100; hsa01230	1C9Y; 1EP9; 1FVO; 1OTH	12.5%
16	KCNH2	Q12809	Potassium voltage-gated channel subfamily H member 2	NA	1BYW; 1UJL; 2L0W; 2L1M; 2L4R; 2LE7; 4HP9; 4HQA	12.5%
17	PRSS1	P07477	Trypsin-1	hsa04080; hsa04972; hsa04974; hsa05164	1FXY; 1TRN; 2RA3; 4WWY; 4WXV	12.2%
18	GRIA2	P42262	Glutamate receptor 2	hsa04024; hsa04080; hsa04713; hsa04720; hsa04723; hsa04724; hsa04728; hsa04730; hsa05014; hsa05030; hsa05031; hsa05033	2WJW; 2WJX; 2XHD; 3R7X; 3RN8; 3RNN; 3UA8	11.8%
19	HAO1	Q9UJM8	Hydroxyacid oxidase 1	hsa00630; hsa01100; hsa01200; hsa04146	2NZL; 2RDT; 2RDU; 2RDW; 2W0U	11.6%
20	ASS1	P00966	Argininosuccinate synthase	hsa00220; hsa00250; hsa01100; hsa01230; hsa05418	2NZ2	11.4%